Luca Mazzarella

@matsadoc

Oncologist, clinician scientist, failed drummer, accomplished father

Milano, Lombardia
Vrijeme pridruživanja: studeni 2011.

Tweetovi

Blokirali ste korisnika/cu @matsadoc

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @matsadoc

  1. proslijedio/la je Tweet

    Intervento straordinario di sulla Sanità, merita di essere ascoltato e diffuso. Non una riga sui giornali di oggi, ci hanno spiegato che è un argomento "tecnico". Tradotto: non è cagnara politica. Condividete, video integrale qui:

    Poništi
  2. 9. stu 2019.

    Guess what? Anti-PDL1 better than chemo in hi PDL1 NSCLC 1st line . Hardly groundbreaking news, will it help bring prices down?

    Poništi
  3. 9. stu 2019.

    Ooops. Just realised i got it wrong. Pd1 actually restores motility after antigen-induced arrest. Was too stunned by the beauty of the images

    Prikaži ovu nit
    Poništi
  4. 9. stu 2019.

    Absolutely mindblowing talk by Ron Germain at . Advanced imaging changes understanding of tumor-immune interaction. Never thought that PD1 comes up to slow down T cells!

    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet
    15. lis 2019.

    Ce la mettono davvero tutta per farmi passare la voglia. Devo ammetterlo. Tuttavia... ...ci vediamo in aula il 25 febbraio 2020.

    Poništi
  6. proslijedio/la je Tweet
    15. lis 2019.

    Forza cara non mancheremo di fare con te la strada che ci separa da qui al 25 febbraio 2020. Non praevalebunt! E' vero siamo ma non sei sola, perché insieme siamo più forti!

    Poništi
  7. proslijedio/la je Tweet
    28. ruj 2019.

    monarchHER trial met its primary endpoint (PFS), suggesting a role for abemaciclib in combination with fulvestrant and trastuzumab in metastatic triple-positive breast cancer

    Poništi
  8. proslijedio/la je Tweet

    Il ha preso la sua decisione. Ho ritenuto di fare chiarezza prima dell’incontro fra e il Presidente della Repubblica, rassegnando le mie dimissioni. @SiamoEuropei

    Poništi
  9. proslijedio/la je Tweet
    9. srp 2019.

    What's beyond PD-1/PD-L1 ICI for , in the pipeline? 🦀 🤔A quite complex landscape... - some 🥇&proof of concepts - many 🥈,🥉&♾ "me too" - sometimes promising targets and..not so rare disappointing results What's the way,now?🛣️

    , , i još njih 3
    Poništi
  10. 5. ožu 2019.

    The scientific and community lost a master who revolutionised treatment with unrivalled style and understatement. I am deeply sad

    Poništi
  11. proslijedio/la je Tweet
    5. sij 2019.

    Un delirante status del vicesindaco triestino secondo il quale Soros organizza un'invasione di migranti tramite Ong per vendere vaccini.

    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    7. sij 2019.

    Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis. ⁦

    Poništi
  13. proslijedio/la je Tweet
    25. pro 2018.

    A phase 1 merry xmas to the of should sound like "merryumab Xmasitine combo with intra best-wishes 002018"... from a global perspective, of course 🌍 best sustainable priority wishes per effectiveness!!

    Poništi
  14. 31. pro 2018.

    seeking for bioinfos!

    Poništi
  15. proslijedio/la je Tweet
    4. pro 2018.

    Un placer compartir conocimiento con expertos internacionales de la talla de Ignacio Melero, Antoni Ribas, Kurt Schalper, Solange Peters, o Luca Mazzarella ayer en el

    , , i još njih 7
    Poništi
  16. proslijedio/la je Tweet
    21. lis 2018.

    CTONG-1103 Neoadjuvant erlotinib vs. Chemo in Stage IIIA-N2 EGFR+ NSCLC 1 year of EGFR TKI makes DFS > to 4 cycles of perioperative chemo. No better surgical outcomes. Without OS data, despite huge effort to enroll pts, not practice changing. Agree?

    Poništi
  17. proslijedio/la je Tweet
    19. lis 2018.

    presents FLAURA resistance mechs. CtDNA by . Caveats to interpret ctDNA. 19% non-shedders. In control: T790M 47%, MET ampl 4%. In osi: 0% T790M 7% C797X, Met amp 15%. A variety of others. Del19/L858R not predictor

    Poništi
  18. proslijedio/la je Tweet

    Obesity predicted to overtake smoking as leading PREVENTABLE cause of cancer. Nice piece on why pancreatic cancer on rise and lifestyle factors that can help minimize risk.

    Poništi
  19. proslijedio/la je Tweet
    4. lip 2018.

    Tom Gajewski discussing our data the potential of artificial intelligence to predict response to immunotherapy

    Poništi
  20. proslijedio/la je Tweet
    3. lip 2018.

    subgroup analysis suggesting the need for a specific design addressing & women plus possible substratification of oncotypeDX scores: a door closed, many windows opened.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·